ERYPED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eryped, and when can generic versions of Eryped launch?
Eryped is a drug marketed by Carnegie and Azurity and is included in two NDAs.
The generic ingredient in ERYPED is erythromycin ethylsuccinate. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eryped
A generic version of ERYPED was approved as erythromycin ethylsuccinate by CARNEGIE on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ERYPED?
- What are the global sales for ERYPED?
- What is Average Wholesale Price for ERYPED?
Summary for ERYPED
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,936 |
| Drug Prices: | Drug price information for ERYPED |
| DailyMed Link: | ERYPED at DailyMed |
Recent Clinical Trials for ERYPED
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yehudith Assouline-Dayan | |
| Assouline-Dayan, Yehudith |
Pharmacology for ERYPED
| Drug Class | Macrolide Antimicrobial Macrolide |
| Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for ERYPED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carnegie | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-003 | Mar 30, 1987 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Carnegie | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Azurity | ERYPED | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-003 | Jul 5, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
